In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Avon Q1

This article was originally published in The Rose Sheet

Executive Summary

Beauty division sales advanced 23% in the first quarter, driven by a 36% gain in skin care revenue, the company announces April 30. Launch of Anew Clinical 2-Step Facial Peeland Line and Wrinkle Correctorand the restage of Retroactive Plus generated combined sales in excess of $50 mil. during the period, CEO Andrea Jung reports. U.S. sales increased 7%, while operating profit in the unit declined 7%, due to a planned non-beauty clearance event. Consolidated net sales were up 19.5% to $1.75 bil. on a reported basis and increased 14% in local currencies. Net income jumped 49.8% to $148.1 mil., as the year-ago period included expenses of $18 mil...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012085

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel